Chamberlin AR - Search Results

1

DOTAP: Structure, hydration, and the counterion effect.

Mihailescu M, Worcester DL, Carroll CL, Chamberlin AR, White SH. Mihailescu M, et al. Among authors: chamberlin ar. Biophys J. 2023 Mar 21;122(6):1086-1093. doi: 10.1016/j.bpj.2023.01.031. Epub 2023 Jan 26. Biophys J. 2023. PMID: 36703558 Free PMC article.

2

Tautomycetin Synthetic Analogues: Selective Inhibitors of Protein Phosphatase I.

Woydziak ZR, Yucel AJ, Chamberlin AR. Woydziak ZR, et al. Among authors: chamberlin ar. ChemMedChem. 2021 Mar 3;16(5):839-850. doi: 10.1002/cmdc.202000801. Epub 2020 Dec 10. ChemMedChem. 2021. PMID: 33301228 Free PMC article.

3

Regulation of mRNA translation by a photoriboswitch.

Rotstan KA, Abdelsayed MM, Passalacqua LF, Chizzolini F, Sudarshan K, Chamberlin AR, Míšek J, Luptak A. Rotstan KA, et al. Among authors: chamberlin ar. Elife. 2020 Feb 13;9:e51737. doi: 10.7554/eLife.51737. Elife. 2020. PMID: 32053109 Free PMC article.

4

Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore Model.

Kaur P, Chamberlin AR, Poulos TL, Sevrioukova IF. Kaur P, et al. Among authors: chamberlin ar. J Med Chem. 2016 May 12;59(9):4210-20. doi: 10.1021/acs.jmedchem.5b01146. Epub 2015 Sep 24. J Med Chem. 2016. PMID: 26371436 Free PMC article.

5

A small molecule screen identifies a novel compound that induces a homeotic transformation in Hydra.

Glauber KM, Dana CE, Park SS, Colby DA, Noro Y, Fujisawa T, Chamberlin AR, Steele RE. Glauber KM, et al. Among authors: chamberlin ar. Development. 2015 Jun 1;142(11):2081. doi: 10.1242/dev.126235. Development. 2015. PMID: 26015540 Free PMC article. No abstract available.

6

Synthesis, molecular modeling, and biological evaluation of novel RAD51 inhibitors.

Zhu J, Chen H, Guo XE, Qiu XL, Hu CM, Chamberlin AR, Lee WH. Zhu J, et al. Among authors: chamberlin ar. Eur J Med Chem. 2015;96:196-208. doi: 10.1016/j.ejmech.2015.04.021. Epub 2015 Apr 9. Eur J Med Chem. 2015. PMID: 25874343 Free PMC article.

7

Novel small molecules disrupting Hec1/Nek2 interaction ablate tumor progression by triggering Nek2 degradation through a death-trap mechanism.

Hu CM, Zhu J, Guo XE, Chen W, Qiu XL, Ngo B, Chien R, Wang YV, Tsai CY, Wu G, Kim Y, Lopez R, Chamberlin AR, Lee EY, Lee WH. Hu CM, et al. Among authors: chamberlin ar. Oncogene. 2015 Mar 5;34(10):1220-30. doi: 10.1038/onc.2014.67. Epub 2014 Mar 24. Oncogene. 2015. PMID: 24662830 Free PMC article.

8

A small molecule screen identifies a novel compound that induces a homeotic transformation in Hydra.

Glauber KM, Dana CE, Park SS, Colby DA, Noro Y, Fujisawa T, Chamberlin AR, Steele RE. Glauber KM, et al. Among authors: chamberlin ar. Development. 2013 Dec;140(23):4788-96. doi: 10.1242/dev.094490. Development. 2013. PMID: 24255098 Free PMC article.

9

A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia.

Zhu J, Zhou L, Wu G, Konig H, Lin X, Li G, Qiu XL, Chen CF, Hu CM, Goldblatt E, Bhatia R, Chamberlin AR, Chen PL, Lee WH. Zhu J, et al. Among authors: chamberlin ar. EMBO Mol Med. 2013 Mar;5(3):353-65. doi: 10.1002/emmm.201201760. Epub 2013 Jan 22. EMBO Mol Med. 2013. PMID: 23341130 Free PMC article.

10

Improving the Fmoc Solid Phase Synthesis of the Cyclic Hexapeptide Complement C5a Antagonist, PMX205.

Delisle Milton RC, Milton SC, Chamberlin AR. Delisle Milton RC, et al. Among authors: chamberlin ar. Int J Pept Res Ther. 2011 Dec;17(4):337-342. doi: 10.1007/s10989-011-9273-9. Int J Pept Res Ther. 2011. PMID: 22707924 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page